Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep274 | Clinical case reports - Pituitary/Adrenal | ECE2016

Hereditary Pheocromocytoma-Paraganglioma Syndrome: a case report

Gallego M. Teresa , Vera Lucia , Meoro Amparo , Del Peso Cristina

Introduction: Paraganglioma (PGL) develops from cells of the parasympathetic and sympathetic system. It usually manifests as a slow- growing and painless mass. PGL may be hereditary, benign, malignant, unilateral or bilateral tumors. In most cases PGL is located around the common carotid artery but may also be located within the middle ear or in the abdomen. Non functional retroperitoneal PGL are rare tumors, usually asymptomatic, and can attain big dimensions. Mutations in th...

ea0038p479 | Thyroid | SFEBES2015

Metastatic differentiated thyroid cancer with undetectable serum thyroglobulin: diagnostic, management and follow-up challenges

Marques Pedro , Ferreira Teresa , Salgado Lucilia , Cabrera Rafael , Leite Valeriano

Background: Serum thyroglobulin (Tg) is a reliable tumor marker in patients with differentiated thyroid carcinoma (DTC). Distant metastases of DTC, particularly in the lung, normally presents with higher levels of Tg, which is useful to follow the disease evolution. We describe a patient with DTC with lung metastases, with undetectable Tg and Tg-antibodies (TgAb).Clinical case: A 52-year-old woman underwent a subtotal thyroidectomy in 1993 because of a g...

ea0037ep1094 | Endocrine tumours | ECE2015

Plasma chromogranin A and chromogranin B concentrations in untreated patients with mid gut carcinoid and their biochemical response to octreotide

Armstrong Lee , Rea Teresa , Johnston Brian , McCance David

We measured chromogranin A (CgA) and chromogranin B (CgB) in 36 patients, recently confirmed to have a midgut carcinoid tumour (MGC), prior to the commencement of octreotide treatment. Blood samples were taken before and after a bolus injection of 50 μg octreotide. There were 21 males, 15 females, age range 28–76 median 61 years.Basal CgA, expressed as times the upper limit of normal (ULN) ranged from 333.3 to 0.5 ULN. Basal CgB ranged from 33....

ea0035p371 | Diabetes (epidemiology, pathophysiology) | ECE2014

GCK-MODY caused by a new mutation in the GCK gene

Caldas Ana Rita , Pereira Teresa , Tavares Purificacao , Cardoso Maria Helena

Introduction: Glucokinase-MODY (Maturity onset diabetes of the young) results from heterozygous mutations in the GCK gene, impairing its enzymatic activity. GCK acts as a glucose sensor in the pancreatic beta cell and regulates insulin secretion. We describe two cases of MODY due to a GCK gene mutation not described until now.Clinical Case: A 63-year-old male is followed in our hospital for 30 years due to diabetes mellitus (DM). He was diagnose...

ea0035p681 | Growth hormone IGF axis basic | ECE2014

Effects of two mTOR inhibitors on in-vitro models of GH-secreting pituitary adenomas

Bellio Mariaenrica , Gagliano Teresa , Zatelli Maria Chiara , Uberti Ettore Degli

Background: Gigantism and acromegaly are the main consequences of GH excess, mainly due to a pituitary adenoma. Surgery is the first therapeutic option, but also medical therapy is employed, being represented mostly by somatostatin analogues (SSA), that reduce both tumour mass and GH hypersecretion. However about 10% of patients is resistant to SSA.PI3K/Akt/mTOR pathway, activated by growth-factors such as IGF1, is important in regulating many cellular p...

ea0070ep10 | Adrenal and Cardiovascular Endocrinology | ECE2020

Malignant neuroblastoma mimicking a metastatic paraganglioma – case report

Maciel Joana , Teresa Alexandre Maria , Simões Helder

Background: Neuroblastomas are malignant tumors that arise from sympathetic plexus or adrenal medulla. Their clinical behavior can range from spontaneous regression to aggressive disease. Like paragangliomas, they have the capacity to secrete catecholamines and to express somatostatin receptors, which is important for diagnostic and treatment purposes. However, the differential diagnosis with paraganglioma can be challenging. We present a case of a catecholamine-producing tumo...

ea0020p311 | Clinical case reports and clinical reports | ECE2009

Graves’ disease and thymic hyperplasia: case report

Carvalho Maria Raquel , Dias Teresa , Baptista Fernando , do Carmo Isabel

Graves’ disease is characterized by the occurrence of antibodies against thyroid-stimulating hormone (TSH) receptor that stimulate the gland to produce T4 and T3. It can be accompanied by an infiltrative orbitopathy and oftalmopathy. Another seldom- regognized feature of this disease is thymic hyperplasia.The authors report the case of a 22-year-old woman with Graves’ disease (TSH receptor antibodies 178 U/l) with exuberant oftalmopathy and an ...

ea0020p335 | Diabetes and Cardiovascular | ECE2009

HLA DQB1 and HLA DQA1 genotypes prevalence in children and adolescence with new-onset diabetes type 1 in the lower Silesia region

Zak Teresa , Malodobra Malgorzata , Zubkiewicz Agnieszka , Noczynska Anna

The first degree relatives of patients with diabetes type 1 have increased genetic risk of developing clinical disease. In the population of Polish diabetic subjects the most frequent alleles are HLA- DRB1*04, DRB1*03, DQA1 and DQB1. The ‘high-risk genotype’ may differ among populations.The aim of this paper was to analyze prevalence of genetic risk factors in patients with new-onset diabetes in Lower Silesia and to compare the data with Polish...

ea0056p654 | Endocrine tumours and neoplasia | ECE2018

Fibroblast-kinome silencing to identifies putative mediator of Triple-negative breast cancer (TNBC) invasion

Gagliano Teresa , Vella Viviana , Bienkowska Kamila , Ditsiou Angeliki , Giamas Georgios

Kinases represent a main therapeutic targets in cancer treatment as their impairing is related to tumor growth and progression. Despite the increasing evidence that tumor microenvironment (TME) signaling influences the behavior of surrounding cancer epithelial cells, still little is known about what changes in stromal cells influence tumor cells’ behavior. TNBC patients are still lacking an effective therapy, as not much is known about the biology of this BC tumor subtype...

ea0063gp70 | Thyroid Autoimmune Disorders | ECE2019

Serum levels of the soluble receptor for advanced glycation end products (AGEs) are reduced and AGEs increased in hashimoto’s thyroiditis (HT)

Ruggeri Rosaria Maddalena , Vicchio Teresa Manuela , Cristani Maria Teresa , Giovinazzo Salvatore , Campenni Alfredo , Cannavo Salvatore , Trimarchi Francesco

Objective: AGEs, compounds formed by the transformation of proteins, are increased in conditions of oxidative stress and promote inflammation by interacting with their receptor (RAGE) on cell membrane. By contrast, the soluble receptor for AGE (sRAGE), that is proteolytically cleaved from cell surface receptor via matrix metalloproteinases, sequester RAGE ligands and act as a cytoprotective and anti-inflammatory agent. AGEs/sRAGE interaction play a role in the pathogenesis of ...